(Q34080236)

30 July 2017

1 reference

25 October 2022

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research (English)

1 reference

highly active antiretroviral therapy

30 July 2017

main subject

anti-retroviral agent

1 reference

based on heuristic

inferred from abstract

AIDS dementia complex

1 reference

25 October 2022

1 reference

18 October 2019

1 reference

26 January 2021

Bruce J Brew

3

1 reference

ORCID Public Data File 2021

Lucette Cysique

series ordinal

1

object named as

Lucette A Cysique

1 reference

30 July 2017

2

Edward K Waters

1 reference

30 July 2017

language of work or name

1 reference

22 November 2011

11 references

30 July 2017

14 February 2019

23 March 2019

25 April 2019

25 June 2019

18 October 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

25 October 2022

11 references

30 July 2017

14 February 2019

23 March 2019

25 April 2019

25 June 2019

18 October 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

25 October 2022

11

1 reference

30 July 2017

page(s)

148

1 reference

Creative Commons Attribution 2.0 Generic

30 July 2017

copyright license

10 references

14 February 2019

23 March 2019

25 April 2019

25 June 2019

18 October 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Neurocognitive impairment and neuroCART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

HIV reservoirs, latency, and reactivation: prospects for eradication

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Updated research nosology for HIV-associated neurocognitive disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Neuroimaging correlates of HIV-associated BBB compromise

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Meta-analysis: neither quick nor easy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

The prevalence and incidence of neurocognitive impairment in the HAART era.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

A statistician looks at met-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

28 October 2018

https://api.crossref.org/works/10.1186%2F1471-2377-11-148

Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252248

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22107790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-11-148

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference